The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care
Abstract
After myeloablative treatment and allogeneic stem cell transplantation (SCT), patients are kept in isolation rooms in the hospital to prevent neutropenic infections. During a 3-year period, patients were given the option of treatment at home after SCT. Daily visits by an experienced nurse and daily phone calls from a physician from the unit were included in the protocol. We compared 36 patients who wished to be treated at home with 18 patients who chose hospital care (control group 1). A matched control group of 36 patients treated in the hospital served as control group 2. All home care patients had hematologic malignancies and 19 were in first remission or first chronic phase. Of the donors, 25 were unrelated. The patients spent a median of 16 days at home (range, 0-26 days). Before discharge to the outpatient clinic after SCT, patients spent a median of 4 days (range, 0-39 days) in the hospital. In the multivariate analysis, the home care patients were discharged earlier (relative risk [RR] 0.33, P = .03), had fewer days on total parenteral nutrition (RR 0.24, P < .01), less acute graft-versus-host disease (GVHD) grades II-IV (RR 0.25,P = .01), lower transplantation-related mortality rates (RR 0.22, P = .04), and lower costs (RR 0.37, P < .05), compared with the controls treated in the hospital. The 2-year survival rates were 70% in the home care group versus 51% and 57% (not significant) in the 2 control groups, respectively (P < .03). To conclude, home care after SCT is a novel and safe approach. This study found it to be advantageous, compared with hospital care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Asymptotically Efficient Rank Invariant Test Procedures
Peto, R., & Peto, J. (1972) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344317 · Cited by 3,393
Cited by
Mistiaen, P., & Poot, E. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004510.pub3 · Cited by 299
Gratwohl, A., Brand, R., Frassoni, F., Rocha, V, Niederwieser, D., Reusser, P., Einsele, H., Cordonnier, C., & for the Acute and Chronic Leukemia Working Parties and the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT) (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705140 · Cited by 292
Graft failure in the modern era of allogeneic hematopoietic SCT
Olsson, R., Remberger, M., Schaffer, M., Berggren, D. M., Svahn, B.-M., Mattsson, J., & Ringden, O. (2013) · Bone Marrow Transplantation · doi:10.1038/bmt.2012.239 · Cited by 284
Self-citation
Metadata
- Authors
- Svahn, B.-M., Remberger, M., Myrbäck, K.-E., Holmberg, K., Eriksson, B., Hentschke, P., Aschan, J., Barkholt, L., & Ringdén, O.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2002-12-15
- Volume
- 100
- Issue
- 13
- Pages
- 4317-4324
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2090071556
- Cited by
- 160
- References
- 1
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. https://app.cochat.ai/papers/10.1182/blood-2002-03-0801
- The paper
- Svahn, B.-M., Remberger, M., Myrbäck, K.-E., Holmberg, K., Eriksson, B., Hentschke, P., Aschan, J., Barkholt, L., & Ringdén, O. (2002). Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood. https://doi.org/10.1182/blood-2002-03-0801
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.